Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.11 USD | -0.45% | +0.91% | -16.54% |
Mar. 15 | Co-Diagnostics, Inc. Appoints Richard Abbott as President | CI |
Mar. 14 | Transcript : Co-Diagnostics, Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
Business Summary
Number of employees: 155
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Diagnostics Technologies
100.0
%
| 34 | 100.0 % | 7 | 100.0 % | -80.09% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
95.1
%
| 25 | 72.1 % | 6 | 95.1 % | -73.73% |
Rest of World
4.9
%
| 10 | 27.9 % | 0 | 4.9 % | -96.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dwight Egan
CEO | Chief Executive Officer | 70 | 13-04-17 |
Brian Brown
DFI | Director of Finance/CFO | 48 | 21-02-21 |
Mark Poritz
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-31 |
Andrew Benson
IRC | Investor Relations Contact | - | - |
Ivory Chang
LAW | General Counsel | - | 23-08-28 |
Reed L. Benson
LAW | General Counsel | 77 | 14-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Reed L. Benson
LAW | General Counsel | 77 | 14-10-31 |
Richard Serbin
BRD | Director/Board Member | 79 | 17-04-30 |
Dwight Egan
CEO | Chief Executive Officer | 70 | 13-04-17 |
James Nelson
BRD | Director/Board Member | 71 | 19-08-29 |
Eugene Durenard
BRD | Director/Board Member | 54 | 19-06-24 |
Edward Murphy
BRD | Director/Board Member | 64 | 19-06-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,108,346 | 30,420,567 ( 84.25 %) | 4,848,678 ( 13.43 %) | 84.25 % |
Company contact information
Co-Diagnostics, Inc.
2401 South Foothill Drive Suite D
84109, Salt Lake City
+801 438 1036
http://www.codiagnostics.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.54% | 34.7M | |
+9.84% | 23.71B | |
-34.52% | 3.23B | |
+12.64% | 1.79B | |
+0.27% | 1.67B | |
+36.05% | 1.38B | |
-3.60% | 1.11B | |
-20.26% | 915M | |
-4.64% | 738M | |
-14.00% | 716M |
- Stock
- Equities
- Stock Co-Diagnostics, Inc. - Nasdaq
- Company Co-Diagnostics, Inc.